Skip to main content

Providing independent clinical excellence since 2005

The SCVC Blog

Cardiovascular care news and articles from our expert team

How to Lose Visceral Adipose Tissue (VAT) and Improve Metabolic Health: A Guide to Sustainable Weight Loss

Cardiology groups, including ours, are increasingly partnering with diabetes and weight management specialists to set up GLP-1 mimetic clinics. These clinics oversee VAT loss and improve glycaemic control for patients with diverse cardiac conditions. The goal is not only to help these patients manage their symptoms but also to provide a holistic approach to cardiovascular and metabolic health, with an emphasis on reducing the burden of visceral fat. Specialist clinics offer patients the chance to access personalised care that targets both fat loss and better glucose regulation, reducing the need for medications and potentially improving overall quality of life. In this blog and associated podcast and YouTube explainer, we set out some of the fundamental principles we care about.

5 things you should consider if your glucose spikes

Patients often ask about home monitoring tools — ECG devices, blood pressure monitors, glucose apps. We now also encourage people to track their waistline and visceral fat, using body composition scales alongside more traditional equipment.To support this, I have created a page of recommended home gadgets that can help patients take greater ownership of their health — a vital step towards a more proactive, prevention-focused model of care, guided by their clinical and educational team.

What are the latest guidelines target for LDL?

For patients who have been diagnosed with an acute coronary syndrome, requiring bypass surgery or stent, or have CT Angiography and or raised FAI, the latest European and UK guidelines reflect the finding that there is no lower limit for LDL yet discovered, basically meaning the lower the better. These recommendations come after new trials with lower targets showed better outcomes. As a result, millions of people around the world need to be looking more carefully at whether they are taking sufficient medication to lower their LDL to these new targets, for the very best outcomes to be achieved.